SOPHiA GENETICS announced that Unilabs is live on the SOPHiA DDM Platform. Unilabs will use SOPHiA GENETICS' technology to test for HRD- status in solid tumors and provide expedited analysis across its network in Switzerland. The implementation of SOPHiAGENETICS' technology across Switzerland will support the company's ability to offer leading testing and analysis to its customer-base and help further the use of precision medicine.